Medical therapy options for aging men with benign prostatic hyperplasia: focus on alfuzosin 10 mg once daily.
about
Genetic association between PSA-158G/A polymorphism and the susceptibility of benign prostatic hyperplasia: a meta-analysis.The impact and management of sexual dysfunction secondary to pharmacological therapy of benign prostatic hyperplasia.Inhibitory effect of Yukmijihwang-tang, a traditional herbal formula against testosterone-induced benign prostatic hyperplasia in rats.Rates of prostate surgery and acute urinary retention for benign prostatic hyperplasia in men treated with dutasteride or finasteride.Metabolic syndrome does not impair the response to alfuzosin treatment in men with lower urinary tract symptoms: a double-blind, randomized, placebo-controlled studyAssociation between polymorphisms of estrogen receptor 2 and benign prostatic hyperplasia.A randomized, comparative, open-label study of efficacy and tolerability of alfuzosin, tamsulosin and silodosin in benign prostatic hyperplasiaCinnamomi Cortex (Cinnamomum verum) Suppresses Testosterone-induced Benign Prostatic Hyperplasia by Regulating 5α-reductase.Pharmacological effects of saw palmetto extract in the lower urinary tractMeasurement of benign prostatic hyperplasia treatment effects on male sexual function.Preliminary assessment of Neck Circumference in Benign Prostatic Hyperplasia in Patients with Metabolic SyndromeAntiproliferative and Antioxidant Effects of Withania coagulans Extract on Benign Prostatic Hyperplasia in Rats.Embolisation of prostatic arteries as treatment of moderate to severe lower urinary symptoms (LUTS) secondary to benign hyperplasia: results of short- and mid-term follow-up.Randomized Controlled Trial to Assess the Efficacy of the Combination Therapy of Alfuzosin and Tadalafil in Patients with Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia.Efficacy and safety of a fixed-dose combination of dutasteride and tamsulosin treatment (Duodart(®) ) compared with watchful waiting with initiation of tamsulosin therapy if symptoms do not improve, both provided with lifestyle advice, in the manageMethyl Jasmonate Ameliorates Testosterone Propionate-induced Prostatic Hyperplasia in Castrated Wistar Rats.Evaluation of patient outcome after discontinuation of alfuzosin treatment for benign prostatic hyperplasia: a multicentre, prospective study.Therapy of calcium oxalate urolithiasis in a rhesus macaque (Macaca mulatta).Identification of cardioprotective drugs by medium-scale pharmacological screening on a cardiac model of Friedreich's ataxia
P2860
Q30234717-CF4495FB-ED1D-42B9-BCCA-2578A55FCB4FQ33650768-B7584476-EDEC-4D58-8845-8D9EA40E71BCQ34240687-CDD77169-BA1E-421D-B7B5-62AE4E7C086DQ36118714-63184F41-F32C-4F25-97CC-D404AA1299F9Q36170066-38045443-C3C1-416F-9ED8-34E3629DB148Q36335781-08272002-08B4-474A-A34A-ADCF3AF0EED9Q36780186-F675F8A1-6E21-4887-B494-A8D7D1CA7620Q37195621-F2951B94-AF1A-4A00-B181-903039B1B4BBQ37406930-4792B59D-58AF-4871-8A0D-AD2F549D8518Q37523227-8AEA96A4-AEC3-4BB7-A412-474F13C6305AQ37626508-5D8D8805-6A0F-416B-879D-67296F02ADF1Q38797324-B3F26B7C-1F77-41C3-8B09-D83099E83398Q40089634-3E20843B-230D-45E6-BFCC-007185B559DCQ40215706-8884330F-C45D-4C8C-B126-3C28F3763D08Q43902268-517AAFDD-3ECE-4360-8729-E047765E14DEQ47329313-BCC4D549-7467-464A-AE5D-B84F696CC02FQ53105128-6BA4FE35-A8DF-4904-B7D4-5BB96126EEEFQ53742515-2484BC59-9873-4989-B12C-EF4146FD50A9Q57175221-6E2ADCBA-7ADB-4FF1-B0E6-38A798F12F8D
P2860
Medical therapy options for aging men with benign prostatic hyperplasia: focus on alfuzosin 10 mg once daily.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Medical therapy options for ag ...... on alfuzosin 10 mg once daily.
@en
Medical therapy options for ag ...... on alfuzosin 10 mg once daily.
@nl
type
label
Medical therapy options for ag ...... on alfuzosin 10 mg once daily.
@en
Medical therapy options for ag ...... on alfuzosin 10 mg once daily.
@nl
prefLabel
Medical therapy options for ag ...... on alfuzosin 10 mg once daily.
@en
Medical therapy options for ag ...... on alfuzosin 10 mg once daily.
@nl
P2860
P356
P1476
Medical therapy options for ag ...... on alfuzosin 10 mg once daily.
@en
P2093
Claus G Roehrborn
Raymond C Rosen
P2860
P304
P356
10.2147/CIA.S3635
P407
P577
2008-01-01T00:00:00Z